[ET Net News Agency, 9 September 2025] 3SBIO (01530) rose 2.5% to HK$35.84.
It hits an intra-day high of HK$36.02, hitting a historical high, and an intra-day low of HK$33.6. The total shares traded was 6.49 million, with a value of HK$227.4m. The active buy/sell ratio is 71:29, with net buying turnover of HK$87.14m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive buying turnover of HK$5.1m, with volume weighted average price of HK$34.884. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$22.06m, with volume weighted average price of HK$35.192.
Basic Information| Nominal | 35.840 | % Chg | +2.46% |
| High | 36.020 | Low | 33.600 |
| Shares Tr | 6.49m | Turnover | 227.4m |
| 10-D SMA | 31.464 | %H.V | 79.307 |
| 20-D SMA | 31.388 | VWAP | 35.052 |
| 50-D SMA | 29.797 | RSI14 | 64.688 |
Status: Hitting a historical high, active buy/sell ratio is 71:29, with net buying turnover of HK$87.14m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| 3SBIO (01530) | 35.84 | +2.46 |
| SINO BIOPHARM (01177) | 8.90 | -1.22 |
| IMMUNEONCO-B (01541) | 12.34 | -17.73 |
| EVEREST MED (01952) | 62.55 | +0.72 |
| KEYMED BIO-B (02162) | 78.55 | +0.06 |
| WUXI XDC (02268) | 66.20 | -1.93 |
| ASCENTAGE-B (06855) | 79.70 | -1.91 |
| ZAI LAB (09688) | 24.74 | -2.29 |
| AKESO (09926) | 138.30 | -2.95 |
| REMEGEN (09995) | 107.50 | +11.11 |
(ed)
